154 related articles for article (PubMed ID: 35313079)
21. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension.
Winter MP; Sharma S; Altmann J; Seidl V; Panzenböck A; Alimohammadi A; Zelniker T; Redwan B; Nagel F; Santer D; Stieglbauer A; Podesser B; Sibilia M; Helbich T; Prager G; Ilhan-Mutlu A; Preusser M; Lang IM
Basic Res Cardiol; 2020 Sep; 115(6):58. PubMed ID: 32880713
[TBL] [Abstract][Full Text] [Related]
22. Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib.
Kim JJ; Vaziri SA; Rini BI; Elson P; Garcia JA; Wirka R; Dreicer R; Ganapathi MK; Ganapathi R
Cancer; 2012 Apr; 118(7):1946-54. PubMed ID: 21882181
[TBL] [Abstract][Full Text] [Related]
23. Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma.
Zhang L; Niu X; Bi Y; Cui H; Li H; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820948060. PubMed ID: 32924793
[TBL] [Abstract][Full Text] [Related]
24. Expression of Vascular Endothelial Growth Factor and Its Receptors in Thyroid Nodular Hyperplasia and Papillary Thyroid Carcinoma: A Tertiary Health Care Centre Based Study.
Mohamad Pakarul Razy NH; Wan Abdul Rahman WF; Win TT
Asian Pac J Cancer Prev; 2019 Jan; 20(1):277-282. PubMed ID: 30678450
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells.
Ye F; Chen HZ; Xie X; Ye DF; Lu WG; Ding ZM
Gynecol Oncol; 2004 Jul; 94(1):125-33. PubMed ID: 15262130
[TBL] [Abstract][Full Text] [Related]
26. Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
Sun Q; Zhang T; Xiao Q; Mei B; Zhang X
Bioengineered; 2022 Mar; 13(3):6500-6508. PubMed ID: 35220896
[TBL] [Abstract][Full Text] [Related]
27. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.
Lee WS; Pyun BJ; Kim SW; Shim SR; Nam JR; Yoo JY; Jin Y; Jin J; Kwon YG; Yun CO; Nam DH; Oh K; Lee DS; Lee SH; Yoo JS
MAbs; 2015; 7(5):957-68. PubMed ID: 25942475
[TBL] [Abstract][Full Text] [Related]
28. Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
Okamoto S; Miyano K; Kitakaze K; Kato H; Yamauchi A; Kajikawa M; Itsumi M; Kawai C; Kuribayashi F
Biochem Biophys Res Commun; 2022 Jan; 587():78-84. PubMed ID: 34872003
[TBL] [Abstract][Full Text] [Related]
29. [The effects of ginsenosides Rg3 on the expressions of VEGF and KDR in human lung squamous cancer cells].
Wang X; Zheng YL; Li K; Lin N; Fan QX
Zhong Yao Cai; 2009 Nov; 32(11):1708-10. PubMed ID: 20218294
[TBL] [Abstract][Full Text] [Related]
30. Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinib.
Maeng CH; Yi JH; Lee J; Hong JY; Choi MK; Jung HA; Park JO; Park SH; Park YS; Kang WK; Lim HY
Anticancer Res; 2013 Oct; 33(10):4619-26. PubMed ID: 24123039
[TBL] [Abstract][Full Text] [Related]
31. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
33. Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis.
Sher I; Adham SA; Petrik J; Coomber BL
Int J Cancer; 2009 Feb; 124(3):553-61. PubMed ID: 19004006
[TBL] [Abstract][Full Text] [Related]
34. The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.
Adamcic U; Skowronski K; Peters C; Morrison J; Coomber BL
Neoplasia; 2012 Jul; 14(7):612-23. PubMed ID: 22904678
[TBL] [Abstract][Full Text] [Related]
35. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.
Gomez-Rivera F; Santillan-Gomez AA; Younes MN; Kim S; Fooshee D; Zhao M; Jasser SA; Myers JN
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4519-27. PubMed ID: 17671138
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
[TBL] [Abstract][Full Text] [Related]
37. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
38. Glucose is a key regulator of VEGFR2/KDR in human epithelial ovarian carcinoma cells.
Adham SA; Coomber BL
Biochem Biophys Res Commun; 2009 Dec; 390(1):130-5. PubMed ID: 19782046
[TBL] [Abstract][Full Text] [Related]
39. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.
Di Desidero T; Fioravanti A; Orlandi P; Canu B; Giannini R; Borrelli N; Man S; Xu P; Fontanini G; Basolo F; Kerbel RS; Francia G; Danesi R; Bocci G
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1465-73. PubMed ID: 23969186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
